Transgene S.A.

TRGNF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$34-$22-$33-$20
Dep. & Amort.$1$2$2$3
Deferred Tax$0$0$0-$1
Stock-Based Comp.$1$0$3$5
Change in WC$11-$7$5-$13
Other Non-Cash-$2-$7$3-$4
Operating Cash Flow-$24-$35-$20-$32
Investing Activities
PP&E Inv.-$3-$3-$2-$1
Net Acquisitions$0$14$0$17
Inv. Purchases$0$0$0-$40
Inv. Sales/Matur.$0$23$22$17
Other Inv. Act.-$0$0$22$23
Investing Cash Flow-$3$35$20$17
Financing Activities
Debt Repay.$29$13$0-$0
Stock Issued$0$0$0$34
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$1-$1-$2
Financing Cash Flow$27$11-$1$16
Forex Effect$1-$0$0$0
Net Chg. in Cash$1$11-$2$1
Supplemental Information
Beg. Cash$16$4$6$5
End Cash$17$16$4$6
Free Cash Flow-$27-$37-$22-$33
Transgene S.A. (TRGNF) Financial Statements & Key Stats | AlphaPilot